Profile | GDS4284 / 244038_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1005.3 | 74 |
GSM687648 | Patient 402 control | 975.606 | 74 |
GSM687653 | Patient 403 control | 1005.88 | 74 |
GSM687658 | Patient 404 control | 690.556 | 69 |
GSM687663 | Patient 411 control | 1017.45 | 74 |
GSM687668 | Patient 422 control | 1026.14 | 74 |
GSM687673 | Patient 424 control | 804.452 | 70 |
GSM687678 | Patient 425 control | 787.098 | 70 |
GSM687683 | Patient 427 control | 811.224 | 70 |
GSM687688 | Patient 428 control | 781.633 | 70 |
GSM687695 | Patient 441 control | 444.027 | 59 |
GSM687699 | Patient 443 control | 678.788 | 68 |
GSM687704 | Patient 444 control | 820.546 | 71 |
GSM687707 | Patient 448 control | 948.14 | 74 |
GSM687712 | Patient 449 control | 978.972 | 74 |
GSM687719 | Patient 450 control | 738.94 | 69 |
GSM687724 | Patient 451 control | 1131.55 | 76 |
GSM687728 | Patient 452 control | 625.794 | 67 |
GSM687646 | Patient 401 treated 24h | 997.603 | 74 |
GSM687649 | Patient 402 treated 24h | 936.587 | 73 |
GSM687665 | Patient 411 treated 24h | 858.56 | 71 |
GSM687651 | Patient 402 treated 4 weeks | 1060.17 | 75 |
GSM687667 | Patient 411 treated 4 weeks | 1194.09 | 76 |
GSM687670 | Patient 422 treated 24h | 1191.87 | 76 |
GSM687671 | Patient 422 treated 4 weeks | 1167.77 | 76 |
GSM687654 | Patient 403 treated 24h | 1226.86 | 77 |
GSM687675 | Patient 424 treated 24h | 866.435 | 72 |
GSM687685 | Patient 427 treated 24h | 667.631 | 68 |
GSM687656 | Patient 403 treated 4 weeks | 1327.81 | 78 |
GSM687677 | Patient 424 treated 4 weeks | 722.682 | 69 |
GSM687687 | Patient 427 treated 4 weeks | 882.237 | 72 |
GSM687692 | Patient 428 treated 4h | 568.187 | 65 |
GSM687716 | Patient 449 treated 4h | 708.332 | 69 |
GSM687722 | Patient 450 treated 4h | 787.229 | 70 |
GSM687680 | Patient 425 treated 24h | 1144.93 | 76 |
GSM687690 | Patient 428 treated 24h | 588.488 | 67 |
GSM687700 | Patient 443 treated 24h | 557.339 | 63 |
GSM687705 | Patient 444 treated 24h | 508.759 | 65 |
GSM687714 | Patient 449 treated 24h | 942.259 | 74 |
GSM687721 | Patient 450 treated 24h | 673.173 | 67 |
GSM687682 | Patient 425 treated 4 weeks | 658.958 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 746.422 | 69 |
GSM687702 | Patient 443 treated 4 weeks | 792.793 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 717.573 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 688.521 | 68 |
GSM687661 | Patient 404 treated 4h | 693.958 | 68 |
GSM687710 | Patient 448 treated 4h | 1128.72 | 76 |
GSM687726 | Patient 451 treated 4h | 1004.43 | 74 |
GSM687730 | Patient 452 treated 4h | 132.924 | 27 |
GSM687660 | Patient 404 treated 24h | 519.355 | 65 |
GSM687697 | Patient 441 treated 24h | 326.043 | 53 |
GSM687709 | Patient 448 treated 24h | 1270.77 | 78 |
GSM687725 | Patient 451 treated 24h | 1066.87 | 75 |
GSM687729 | Patient 452 treated 24h | 639.573 | 68 |
GSM687727 | Patient 451 treated 4 weeks | 753.422 | 69 |
GSM687731 | Patient 452 treated 4 weeks | 602.323 | 66 |